Meclizine hydrochloride 25 MG Oral Tablet [Dramamine Nausea Relief] — RxCUI 2110527
RxNorm drug concept · Semantic branded drug
RxCUI 2110527
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2110527
Official nameMeclizine hydrochloride 25 MG Oral Tablet [Dramamine Nausea Relief]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDramamine Nausea Relief 25 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Meclizine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
- For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
- Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
- This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
🕸️ Concept Web — How Meclizine hydrochloride 25 MG Oral Tablet [Drama... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Meclizine hydrochloride 25 MG Oral Tablet [Dramamine Nausea Relief]
RxCUI 2110527 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Meclizine
6676IN -
Meclizine hydrochloride
82041PIN
-
Meclizine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Dramamine Nausea Relief
2110522BN
-
Dramamine Nausea Relief
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Meclizine Oral Tablet
372731SCDF -
Meclizine hydrochloride Oral Tablet
2645970SCDFP -
Meclizine Oral Product
1159177SCDG -
Meclizine Pill
1159178SCDG -
Meclizine hydrochloride Oral Product
2659152SCDGP -
Meclizine hydrochloride Pill
2660116SCDGP -
Meclizine Oral Tablet [Dramamine Nausea Relief]
2110524SBDF -
Meclizine hydrochloride Oral Tablet [Dramamine Nausea Relief]
2657551SBDFP - +5 more in this family
-
Meclizine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Meclizine hydrochloride 25 MG Oral Tablet
995666SCD -
Meclizine hydrochloride 25 MG
995631SCDC -
Meclizine hydrochloride 25 MG [Dramamine Nausea Relief]
2110523SBDC
-
Meclizine hydrochloride 25 MG Oral Tablet
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Meclizine hydrochloride 25 MG Oral Tablet
SCD · 995666 -
Meclizine hydrochloride 25 MG
SCDC · 995631 -
Meclizine Oral Tablet
SCDF · 372731 -
Meclizine hydrochloride Oral Tablet
SCDFP · 2645970 -
Meclizine Oral Product
SCDG · 1159177 -
Meclizine Pill
SCDG · 1159178 -
Meclizine hydrochloride Oral Product
SCDGP · 2659152 -
Meclizine hydrochloride Pill
SCDGP · 2660116
Brand-Name Concepts
-
Meclizine hydrochloride 25 MG [Dramamine Nausea Relief]
SBDC · 2110523 -
Meclizine Oral Tablet [Dramamine Nausea Relief]
SBDF · 2110524 -
Meclizine hydrochloride Oral Tablet [Dramamine Nausea Relief]
SBDFP · 2657551 -
Dramamine Nausea Relief Oral Product
SBDG · 2110525 -
Dramamine Nausea Relief Pill
SBDG · 2110526 -
Dramamine Nausea Relief
BN · 2110522
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2110527 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 63029-0905-10 | 2 BLISTER PACK in 1 BOX (63029-905-10) / 5 TABLET in 1 BLIS... | DRAMAMINE - N | Medtech Products Inc. | 2018-01-15 |
Observed labelers:
Medtech Products Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.